Immune checkpoint inhibitors and multiple sclerosis (P1-1.Virtual)

被引：0
|
作者：
Conway, Sarah [1 ]
Pua, Danielle Kei [1 ]
Holroyd, Kathryn [1 ]
Galetta, Kristin [1 ]
Bhattacharyya, Shamik [1 ]
机构：
[1] Brigham & Womens Hosp, Boston, MA 02115 USA
来源：
NEUROLOGY | 2022年 / 98卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Lymphocyte Depletion and Repopulation Following Subcutaneous or Intravenous Alemtuzumab in Patients with Progressive Multiple Sclerosis: SCALA Study Results (P1-1.Virtual)
    Acevedo, Breogan Rodriguez
    Nos, Carlos
    Baker, Darren
    Wu, Yanzhen
    Chirieac, Magdalena
    Montalban, Xavier
    NEUROLOGY, 2022, 98 (18)
  • [22] Olfaction and apathy in early Parkinsons disease (P1-1.Virtual)
    Nunez, Alfonso Enrique Martinez
    Latack, Katie
    Situ-Kcomt, Miguel
    Mahajan, Abhimanyu
    NEUROLOGY, 2022, 98 (18)
  • [23] Opsoclonus Myoclonus Syndrome in Uterine Malignancy (P1-1.Virtual)
    Chappidi, Maithreyi
    Burton, Erik
    NEUROLOGY, 2022, 98 (18)
  • [24] Disability Progression and Improvement Among Active and Nonactive Secondary Progressive Multiple Sclerosis Patients in Placebo Arms of Clinical Trials (P1-1.Virtual)
    Xun, Pengcheng
    Sadetsky, Natalia
    Kresa-Reahl, Kiren
    Bogdanovich, Sasha
    Barlev, Arie
    Watson, Crystal
    NEUROLOGY, 2022, 98 (18)
  • [25] Exploring the evolution of functional and structural damage along the visual pathway in multiple sclerosis related acute optic neuritis. (P1-1.Virtual)
    Guerrieri, Simone
    Pisa, Marco
    Sangalli, Francesca
    Martinelli, Vittorio
    Comi, Giancarlo
    Leocani, Letizia
    NEUROLOGY, 2022, 98 (18)
  • [26] Inflammatory disease in people with multiple sclerosis treated with immune checkpoint inhibitors
    Afzal, Saira
    Li, Yadi
    Lapin, Brittany
    Hua, Le H.
    Kennedy, Lucy Boyce
    Ma, Wen Wee
    Mcginley, Marisa
    Cohen, Jeffrey A.
    Kunchok, Amy
    ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2025, 12 (03): : 643 - 647
  • [27] The Effect of Demographic Factors on Prescription of High-Efficacy Disease-Modifying Therapies in Relapsing Remitting Multiple Sclerosis (P1-1.Virtual)
    Grimshaw, Jack
    Mallawaarachchi, Gagana
    Jackson, Thomas
    Das, Joyutpal
    Rog, David
    NEUROLOGY, 2022, 98 (18)
  • [28] Use of immune checkpoint inhibitors in patients with lung cancer and multiple sclerosis
    Martinez, Belen Iglesias
    Insa, Amelia
    Ygual, Guillermo Cervera
    Gascon, Francisco
    Moran, Jose Andres Dominguez
    Martin-Martorell, Paloma
    LUNG CANCER, 2025, 202
  • [29] Phenotype and recovery from relapses in patients with Relapsing Remitting Multiple Sclerosis with their first DMT prescription: an Italian registry study (P1-1.Virtual)
    D'Amico, Emanuele
    Zanghi, Aurora
    Patti, Francesco
    NEUROLOGY, 2022, 98 (18)
  • [30] Resting State Effective Connectivity Abnormalities of the Papez Circuit Contribute to Explain Worse Cognitive Performances in Multiple Sclerosis Patients (P1-1.Virtual)
    Marchesi, Olga
    Bonacchi, Raffaello
    Valsasina, Paola
    Rocca, Maria A.
    Filippi, Massimo
    NEUROLOGY, 2022, 98 (18)
12345